The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patra, A. K.
Right arrow Articles by Bommhardt, U. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patra, A. K.
Right arrow Articles by Bommhardt, U. H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2006, 177: 4567-4576.
Copyright © 2006 by The American Association of Immunologists, Inc.

PKB Rescues Calcineurin/NFAT-Induced Arrest of Rag Expression and Pre-T Cell Differentiation1

Amiya K. Patra*, Thomas Drewes{ddagger}, Swen Engelmann{ddagger}, Sergei Chuvpilo{dagger}, Hiroyuki Kishi§, Thomas Hünig*, Edgar Serfling{dagger} and Ursula H. Bommhardt2,{ddagger}

* Institute of Virology and Immunobiology and {dagger} Institute of Pathology, Julius-Maximilians University Würzburg, Würzburg, Germany; {ddagger} Institute of Immunology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany; and § Department of Immunology, Toyama Medical and Pharmaceutical University, Toyama, Japan


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Protein kinase B (PKB), an Ag receptor activated serine-threonine kinase, controls various cellular processes including proliferation and survival. However, PKB function in thymocyte development is still unclear. We report PKB as an important negative regulator of the calcineurin (CN)-regulated transcription factor NFAT in early T cell differentiation. Expression of a hyperactive version of CN induces a profound block at the CD25+CD44– double-negative (DN) 3 stage of T cell development. We correlate this arrest with up-regulation of Bcl-2, CD2, CD5, and CD27 proteins and constitutive activation of NFAT but a severe impairment of Rag1, Rag2, and intracellular TCR-beta as well as intracellular TCR-{gamma}{delta} protein expression. Intriguingly, simultaneous expression of active myristoylated PKB inhibits nuclear NFAT activity, restores Rag activity, and enables DN3 cells to undergo normal differentiation and expansion. A correlation between the loss of NFAT activity and Rag1 and Rag2 expression is also found in myristoylated PKB-induced CD4+ lymphoma cells. Furthermore, ectopic expression of NFAT inhibits Rag2 promoter activity in EL4 cells, and in vivo binding of NFATc1 to the Rag1 and Rag2 promoter and cis-acting transcription regulatory elements is verified by chromatin immunoprecipitation analysis. The regulation of CN/NFAT signaling by PKB may thus control receptor regulated changes in Rag expression and constitute a signaling pathway important for differentiation processes in the thymus and periphery.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Thymic T cell development is characterized by multiple steps of differentiation and proliferation, which ultimately lead to the emergence of functional self-MHC-restricted CD4+ and CD8+ T cells (1). Before the CD4+CD8+ double-positive (DP)3 stage, when thymocytes undergo positive and negative selection, they mature through four distinct CD4–CD8– double-negative (DN) developmental stages, which are marked by the sequential gain and loss of the CD44 and CD25 surface molecules (2). DN1 cells (CD44+CD25–) differentiate to DN2 (CD44+CD25+) cells and then transit to the DN3 (CD25+CD44–) stage. Cells of the DN4 (CD25–CD44–) stage have down-regulated both CD25 and CD44 and undergo extensive expansion giving rise to DP cells.

At the DN3 stage, Rag1 and Rag2 proteins are expressed and initiate VDJ recombination of the TCR-beta locus. This leads to expression of the pre-TCR, which consists of a productively rearranged TCR beta-chain and the invariant pre-TCR {alpha}-chain associated with CD3 molecules (3, 4). Signals initiated via the pre-TCR are essential for survival (a process known as beta selection), which triggers multiple signaling cascades leading to differentiation into DN4 cells, expansion and eventually to TCR-{alpha} locus rearrangement at the DP stage and replacement of the pre-TCR by a functional {alpha}beta TCR.

A considerable number of genetic and biochemical data show that defects in either Rag1 or Rag2 expression, TCR-beta gene rearrangement or pre-TCR/CD3 assembly as well as in activation of downstream signaling molecules and transcription factors lead to a partial or total arrest of thymocyte development at the DN3 stage (5, 6, 7, 8). Interestingly, signals evoked from the pre-TCR or {alpha}beta TCR are biochemically linked to a similar set of protein kinases, phosphatases, adaptor molecules, and transcription factors (9). One common second messenger of pre-TCR (10) and mature TCR signaling is intracellular calcium, the levels of which are crucial for a number of downstream pathways, most notably activating the ubiquitously expressed serine-threonine-specific phosphatase calcineurin (CN) (11, 12).

Calcineurin, consisting of the large catalytic subunit A and the regulatory subunit B, is a specific target of the immunosuppressive drugs cyclosporin A (CsA) and FK506, which can completely block the calcium-dependent activation of T cells (13). Pharmacological approaches using CsA/FK506 in vivo and in vitro have shown that CN is an important regulator of thymocyte differentiation and selection (14, 15, 16, 17, 18, 19). More recently, genetic ablation of the CN-A beta subunit (20) or the CN-B1 regulatory subunit (21) as well as transgenic (tg) expression of a constitutively active form of CN in the thymus (22) have confirmed that CN is required for positive but not for negative selection of DP cells.

Prominent targets of CN are the NFAT transcription factors (11, 23, 24). The four genuine NFAT members (c1–c4) share significant sequence homology, in particular in their DNA binding region. CN dephosphorylates 13 serine residues within the regulatory region of NFAT, resulting in its nuclear translocation and activation. Cessation of CN activity and rephosphorylation of NFAT by (a) nuclear protein kinase(s) results in relocalization to the cytosol. Genetic inactivation of NFATc1, c2, and c3, which are expressed in lymphocytes, has elucidated and confirmed both their common and individual roles in peripheral T cell activation, cytokine production, and Th cell differentiation (11) as well as in control of cell cycle (25) and apoptosis (26). During thymocyte development, individual NFAT family members show distinct expression patterns (27, 28), but single or double deficiency of specific NFAT isoforms has either no or a mild effect on T cell maturation (29, 30, 31).

TCR-induced NFAT activation is associated with the induction of various downstream signaling cascades including that of PI3K. A prominent target of PI3K signaling is the serine-threonine kinase protein kinase B (PKB/Akt), which is an essential regulator of T cell activation and survival, and is critically involved in the development of various types of cancer, including T cell lymphoma (32, 33). The role of serine-threonine kinases in thymocyte development has become obvious more recently, since overexpression of specific isoforms of PKB (34) or mutation of their upstream regulators, including PTEN (35, 36) or phosphoinositide-dependent kinase 1 (37), reveal strong effects on thymocyte survival, selection, and differentiation.

In a previous study, we reported that a constitutively active version of PKB enables T cell proliferation in the presence of CsA and independent of the effective nuclear accumulation of NFAT proteins (38). Here, we studied the interaction of PKB with NFAT signaling in early thymocyte development by analyzing double-tg mice expressing both, a constitutively active form of CN ({Delta}Cam) and a constitutively active form of human myristoylated PKB{alpha} (myrPKB). We find that overexpression of CN/NFAT arrests thymocyte development at the DN3 to DN4 transition and identify NFAT proteins as novel regulators of rag expression. Remarkably, the {Delta}Cam-induced defect can be rescued by active PKB, suggesting regulation of NFAT activity by PKB to be crucial for normal beta selection of thymocytes.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
DNA constructs and mice

The truncated murine CN-A mutant ({Delta}Cam) was previously described (39) and provided by R. Kincaid (Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA). The 1.2-kb DNA fragment was cloned into the BamHI sites of the expression cassette harboring the murine proximal lck promoter, a 3' human growth hormone fragment and the human CD2 locus control region (40). SpeI fragments were injected into oocytes from NMRI mice. Founder mice were crossed to NMRI or C57/BL6 mice for further analysis. Genomic integration of the {Delta}Cam transgene was determined by PCR of genomic tail DNA using the primers forward 5'-CCG AGC CCA AGG CGA TTG ATC C-3' and reverse 5'-CCC GGT TTC TGA TGA CTT CCT TCC-3'. Tg mice expressing a membrane-targeted myrPKB under control of the human CD2 promoter have been previously described (41). Mice heterozygous for {Delta}Cam were crossed with myrPKB tg or OT1 TCR tg (42) mice (both on C57/BL6 background). In all experiments, F1 littermates negative for both {Delta}Cam and myrPKB, and positive only for either {Delta}Cam or myrPKB, were used as wild-type (wt) control or control for {Delta}Cam or myrPKB tg mice, respectively. Mice used were 1-day-old or 6- to 10-wk-old unless mentioned otherwise. Identical results were obtained with {Delta}Cam tg mice crossed to the C57BL/6 background for at least five generations and with {Delta}Cam tg mice crossed to a second myrPKB tg line.

Abs and flow cytometry

Thymus single-cell suspensions were prepared for flow cytometry analysis. For three-color analysis, thymocytes were immunostained with CD4 (GK1.5), CD8 (YTS.169), CD5 (53-7.3), CD24 (HSA, M1/69), CD25 (PC61), CD44 (IM7), CD2 (RM2-5), IL-7R{alpha} (B12-1), CD27 (LG.3A10), TCR-beta (H57-597), or TCR-{gamma}{delta} (GL3) mAbs labeled with FITC, PE, or biotin in PBS containing 0.1% BSA and 0.01% sodium azide. Biotin-coupled Abs were revealed with streptavidin-CyChrome. For further analysis of DN3 cells, thymocytes were gated on CD4–CD8–CD25+ cells. Abs were purchased either from BD Pharmingen or were prepared in our laboratory from hybridoma supernatants. For detection of apoptosis in DN3 cells, CD4–-, CD8–-, and CD25-labeled thymocytes were incubated with Annexin VFITC (BD Pharmingen) for 15 min at room temperature. Cells were analyzed by three-color flow cytometry using a FACSCalibur and CellQuest software (BD Biosciences). DN thymocytes were enriched by treatment of total thymocytes with Abs against CD4 (GK1.5), CD8 (TiB105), NK1.1 (1D4), CD19 (1D3), and MHC class II (2G9) followed by negative selection using BioMag anti-rat-IgG coupled to magnetic beads (Qiagen). Purity of DN cells was 90–95% as verified by FACS analysis. After depletion of DP cells, DN3 cells were isolated by gating on CD25+CD44– cells and sorting on a FACSVantage (BD Biosciences). CD4+ T cells from lymph nodes of wt mice and myrPKB homozygous mice with lymphoma were either electronically sorted or purified by depletion of CD4– cells using the CD4+ T cell isolation kit from Miltenyi Biotec. CD4+ T cells were stimulated with plate-bound CD3 Abs (145.2C11, 5 µg/ml; BD Pharmingen) for 4 h before cells were harvested and RNA or protein extracts were prepared.

RT-PCR

Total cellular RNA from isolated DN thymocytes or CD4+ T cells was prepared with TRIzol reagent (Invitrogen Life Technologies) and cDNA was synthesized with SuperScript reverse transcriptase (Invitrogen Life Technologies) from 1 µg of RNA as described by the manufacturer’s protocol. Each sample was normalized by PCR for beta-actin or hypoxanthine phosphoribosyltransferase (HPRT). Serially diluted cDNA was analyzed for expression of CN (detecting bp 301–909 of its N terminus), {Delta}Cam, myrPKB, Rag1, Rag2, beta-actin, or HPRT using the following primers: CN, forward 5'-AAG GAG GGA AGG CTG GAA GA-3' and reverse 5'-GGC ATC CAT ACA GGC ATC AT-3'; {Delta}Cam, forward 5'-CCG AGC CCA AGG CGA TTG ATC C-3' and reverse 5'-CCC GGT TTC TGA TGA CTT CCT TCC-3'; myrPKB, forward 5'-AGA TTT CCT GTC CCC TCT CAG G-3' and reverse 5'-TGT TGG ACC CAG CTT TGC AG-3'; Rag1, forward 5'-TGC AGA CAT TCT AGC ACT CTG-3' and reverse 5'-ACA TCT GCC TTC ACG TCG AT-3'; Rag2, forward 5'-TCT CTA AAG ATT CCT GCT ACC TC-3' and reverse 5'-TGG AAT TCA CTG CTG GGG TAC-3'; beta-actin, forward 5'-CCA GGT CAT CAC TAT TGG CAA GGA-3' and reverse 5'-GAG CAG TAA TCT CCT TCT GCA TCC-3'; HPRT, forward 5'-GCT GGT GAA AAG GAC CTC TC-3' and reverse 5'-CAC AGG ACT AGA ACA CCT GC-3'.

Western blot analysis

For immunoblotting, cytoplasmic and nuclear protein extracts of purified CD4+ T cells or whole cell lysates of DN cells were prepared as described (38). Protein concentration was determined with Bradford’s reagent (Bio-Rad) and 30 µg of whole cell and 10 µg of cytoplasmic or nuclear protein extract was fractionated by 8% SDS-PAGE, transferred to nitrocellulose membranes and analyzed for expression of phospho-PKB (Ser473) and PKB (both Cell Signaling Technology), Rag1 and beta-actin (both Santa Cruz Biotechnology), NFATc1 (Axxora), or NFATc2 (a gift from Dr. A. Rao, Center for Blood Research, Harvard Medical School, Boston, MA). Primary Abs were detected by goat anti-rabbit (Santa Cruz Biotechnology), goat anti-mouse, or rabbit anti-goat Abs (Jackson ImmunoResearch Laboratories) coupled with HRP and ECL (Pierce).

Intracellular TCR-beta staining

For intracellular staining, total thymocytes were first stained for cell surface CD4, CD8, and CD25 molecules. Cells were then fixed with 1% paraformaldehyde (10 min at room temperature) and permeabilized in PBA (1x PBS, 5% BSA, and 0.02% NaN3) containing 0.5% saponin (10 min at room temperature) (43). Permeabilized cells were incubated with FITC-labeled mAbs against TCR-beta, TCR-{gamma}{delta}, or Bcl-2 (BD Pharmingen) diluted in PBA containing 0.5% saponin for 30 min at 4°C. Cells were washed twice in 1 ml of PBA/0.5% saponin, once with PBS/0.1% BSA/0.01% azide, and analyzed by FACS.

Newborn thymic organ culture

Thymic lobes from neonatal (day 1) wt and {Delta}Cam tg mice were placed on nucleopore membranes (Whatman) and cultured on 2 ml of complete RPMI 1640 medium containing 10% FCS in the absence or presence of 100 ng/ml CsA (Sigma-Aldrich) for 4 days. Subsequently, single-cell suspensions were prepared and thymocyte subpopulations were determined by flow cytometry. Intracellular expression of the TCR beta-chain was analyzed gating on the CD4–CD8– population.

Transfections and luciferase reporter assays

EL4 lymphoma cells were grown in RPMI 1640 medium containing 10% FCS, 0.352 µM 2-ME, 100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C and 5% CO2. Transfection of cells was done using FuGene 6 reagent (Roche) according to the manufacturer’s protocol. Briefly, 1 µg of total DNA solution containing 50 ng of murine Rag2-luciferase reporter gene, 50 ng of {Delta}Cam expression vector (39), 400–800 ng of human NFATc1 (26), NFATc2 expression vector, or empty vector DNA, was mixed with 4 µl of Fugene and evenly spread over 1.5–3.0 x 105 cells/well. At 26 h after transfection, cells were induced with PMA (Sigma-Aldrich) and ionomycin (Calbiochem), each 100 ng/ml, for 16–20 h when cells were harvested and luciferase reporter activity was determined. The luciferase reporter construct contained the TCR beta-chain enhancer and murine Rag2 promoter region from nt –251 to nt +147 (44).

Chromatin immunoprecipitation (ChIP) assay

ChIP analysis was conducted essentially following the protocol of Abcam (<www.abcam.com/technical>). Briefly, 4–6 x 106 freshly isolated thymocytes from wt or {Delta}Cam tg mice were cross-linked using 1% formaldehyde. Isolated nuclei were sonicated so that the average length of chromosomal DNA became 500-1000 bp. Chromatin solution was precleared with Sepharose G, and chromatin was immunoprecipitated by incubating with 6–8 µg of NFATc1 Ab (Axxora) or an isotype-matched polyclonal mouse IgG Ab (Jackson ImmunoReserach Laboratories) overnight at 4°C. Immune complexes were collected on protein G-Sepharose beads and immunoprecipitates were eluted with 1% SDS, 50 mM NaHCO3. After reversal of cross-links and deproteination, the presence of Rag1 and Rag2 promoter sequences was analyzed by PCR using the following oligonucleotide primers: Rag1 promoter forward 5'-CAT TCT CAG GAG ATG AAA TGA CAG C-3' and reverse 5'-TTG TCC CAT AGT GCA CAA TGC-3'; and Rag2 promoter forward 5'-CTT AAG ACA GTC ATT TTT TGT GGG-3' and reverse 5'-AAG CCA GGA ATT AAA CTC GGC TC-3'. The sequence for the Rag enhancer element 5' of the Rag2 promoter was taken from GenBank (accession number AY215076) as previously published (45). Primers used to detect NFATc1 binding within this sequence were: Rag enhancer (4) nt 1171–1193 forward 5'-ATC AGC AAG TGT TGG TAT TC-3' and nt 1630–1650 reverse 5'-CTT TAT TCA GCA TTC AGA AGG-3'; Rag enhancer (7) nt 18716–18741 forward 5'-CCC ATG TTC AGA TCA ACT AAT AAT CC-3' and nt 19402–19423 reverse 5'-AAA CTC CAA GCT CTG AGT CAA C-3'. Primers to detect NFATc1 binding in the described Erag enhancer (46) were nt 14–36 forward 5'-CAC CAT TCA ATA TTC AGG AGG G-3' and nt 346–366 reverse 5'-CTG CTG TAG AAA AAT ACC ACA GAG-3'.

Confocal microscopy

Single-cell suspensions of thymocytes were fixed in 0.5% formaldehyde for 10 min at room temperature and cytospinned onto poly-lysine-coated glass slides. Slides were incubated for 15 s in chilled acetone (–20°C) and cells were permeabilized by incubating in chilled methanol (–20°C) for 3 min. Subsequently, cells were washed thrice in PBS and incubated with goat anti-mouse Fc block (BD Pharmingen) for 15 min in a humid chamber. Afterward, 40 µl of primary Ab solution containing CD4 (Alexa Fluor 647; Caltag Laboratories) and CD8{alpha} (Alexa Fluor 488; Caltag Laboratories) and NFATc1 or NFATc3 Abs (Santa Cruz Biotechnology) appropriately diluted in PBS/1% BSA was added to the cells for 45 min. Cells were washed thrice in PBS and were further incubated with donkey anti-rabbit Alexa Fluor 555 Abs (Molecular Probes) for 45 min in the dark. Cells were washed thrice in PBS and twice in dH2O and then counterstained with DAPI (4',6'-diamidino-2-phenylindole; Sigma-Aldrich) for 5 min at room temperature for nuclear staining. Stained thymocytes were analyzed for NFAT expression in CD4–CD8– cells using a TCS SP2 Leica confocal microscope and Leica confocal software.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
MyrPKB rescues the {Delta}Cam-induced block in DN3 to DN4 transition

To determine a role of PKB in regulating CN signaling during early intrathymic T cell development, we generated mice double-tg for active PKB and a constitutively active version of the large CN subunit A ({Delta}Cam) (39). {Delta}Cam, lacking CN's calmodulin binding and autoinhibitory domains, was expressed in early thymocytes under control of the proximal p56lck promoter (Fig. 1A). Compared with endogenous expression of CN in wt mice, expression of {Delta}Cam was elevated >10-fold in the {Delta}Cam tg mouse line used for all analyses (Fig. 1B). {Delta}Cam tg mice were crossed with mice expressing myrPKB under control of the human CD2 promoter (41). {Delta}Cam and myrPKB RNA expression were detected in sorted DN3 cells by RT-PCR (Fig. 1C), and expression of active PKB in {Delta}Cam/myrPKB DN thymocytes was confirmed by Western blot analysis (Fig. 1D).


Figure 1
View larger version (32K):
[in this window]
[in a new window]
  		FIGURE 1. Generation of {Delta}Cam/myrPKB double-tg mice. A, Schematic representation of the injection fragment used to generate {Delta}Cam tg mice. The human CN-A catalytic subunit containing a deletion of the calmodulin binding and autoinhibitory domain ({Delta}Cam) was cloned under the control of the proximal p56lck promoter and CD2 locus control region (LCR). The polyadenylation site was provided by a 2.1-kb fragment of the human growth hormone (hGH) gene. B, RT-PCR analysis of CN expression in CD4–CD8– DN cells of wt, myrPKB tg (PKB), {Delta}Cam tg ({Delta}Cam), and {Delta}Cam/myrPKB double-tg ({Delta}Cam/PKB) mice. MyrPKB tg mice express a constitutively active form of human PKB{alpha} under control of the human CD2 promoter. cDNA was serially diluted, and actin expression was used to control amounts of cDNA applied. C, Expression of {Delta}Cam and myrPKB in isolated CD25+CD44– DN3 cells from the indicated mouse lines was analyzed by RT-PCR. HPRT RT-PCR was used as control. D, Expression of phosphorylated active PKB (Ser473), total PKB, and beta-actin, serving as loading control, was analyzed in DN cells of {Delta}Cam tg and {Delta}Cam/myrPKB double-tg mice by Western blot. The lower PKB band represents endogenous (end.) PKB and the upper PKB band tg myrPKB.

 
Compared with wt or myrPKB tg littermate mice, on average {Delta}Cam tg mice exhibited a 18-fold reduction in thymus cellularity as total thymocyte number from 6- to 8-wk-old wt or myrPKB tg mice on average was 128 x 106 but only 7 x 106 for {Delta}Cam tg mice. Analysis of thymocyte subpopulations in {Delta}Cam tg mice revealed a drastic loss of DP cells, with only 5% DP cells in {Delta}Cam tg vs 86% in wt mice, and a marked increase in the percentage of DN cells (Fig. 2A, top, and B). The impact of {Delta}Cam on thymic cellularity and composition of cell subsets was already obvious in newborn mice (Fig. 2A, bottom), suggesting the loss of DP thymocytes is linked to a block in early thymocyte differentiation. This idea was supported by further characterization of the DN population into DN1-DN4 subsets, which revealed that ~80–90% of {Delta}Cam DN thymocytes are CD25+CD44– DN3 cells (Fig. 2C). Therefore, the loss of DP cells in {Delta}Cam tg mice is due to a developmental arrest at the transition from the DN3 to DN4 stage of early thymocyte differentiation.


Figure 2
View larger version (51K):
[in this window]
[in a new window]
  		FIGURE 2. MyrPKB rescues thymocyte development in {Delta}Cam tg mice. A, Distribution of thymocyte subsets in wt, myrPKB tg (PKB), {Delta}Cam tg ({Delta}Cam), and {Delta}Cam/myrPKB double-tg ({Delta}Cam/PKB) mice, either age 6 wk (top) or 1 day (bottom). Single-cell suspensions of thymocytes were stained for CD4 and CD8 surface expression and analyzed by flow cytometry. Values in each quadrant give the percentage of cells in the corresponding thymocyte subset. Thymus cellularity (x 106) for individual mice is provided at the top of each plot. B, Absolute cell numbers and percentages of DN and DP cells in wt, myrPKB tg, {Delta}Cam tg, and {Delta}Cam/myrPKB double-tg mice. Data shown represent 10–24 individual mice per group. C, MyrPKB rescues the DN3 developmental block induced by {Delta}Cam. DN thymocytes from the four indicated mouse strains were analyzed for CD25 and CD44 after gating on cells negative for CD4 and CD8 expression. The percentages of the individual DN1-DN4 subsets are indicated in each quadrant.

 
Strikingly, simultaneous expression of myrPKB significantly alleviated the DN3 arrest in {Delta}Cam tg mice and allowed efficient T cell maturation such that the thymic phenotype of {Delta}Cam tg mice closely resembled that of littermate wt mice (Fig. 2, A–C). Thymocyte numbers in {Delta}Cam/myrPKB double-tg mice were increased on average by 10-fold ranging from 30 to 140 x 106. The percentage of DP cells was restored to an average of 70% and the percentage of DN cells declined to 13%, closely approaching values for wt mice. Thus, myrPKB releases the DN3-DN4 transitional block evoked by {Delta}Cam, presumably by counteracting {Delta}Cam-induced downstream signaling events, including activation of NFAT factors. The results from this study were also observed with a second myrPKB tg mouse line (data not shown), indicating that the effective rescue of DN3 cells in {Delta}Cam tg mice is mediated via active PKB.

Phenotype of {Delta}Cam and {Delta}Cam/myrPKB DN3 cells

To understand the molecular mechanisms whereby myrPKB can antagonize the differentiation block imposed by active CN, we first investigated several surface Ags that are modulated during progression from the DN3 to DP stage. Expression of CD2 and CD5 molecules is up-regulated by pre-TCR signals as cells transit from the DN3 to DN4 stage (47, 48). Analysis of CD4–CD8–CD25+ DN3 cells from {Delta}Cam tg mice showed that ~47% of cells exhibited enhanced expression of CD2 compared with ~25% in DN3 cells from myrPKB tg or wt littermate mice (Fig. 3A). High level CD5 expression was detected in 87% of {Delta}Cam DN3 cells but on average in only 23% DN3 cells of the other three tg mouse lines. The majority of {Delta}Cam DN3 cells also showed lower HSA (CD24) expression, whereas IL-7R{alpha} level was similar to control cells. Notably, myrPKB reverted the expression levels of the analyzed surface Ags in {Delta}Cam DN3 cells toward those detected in wt cells, indicating that {Delta}Cam DN3 cells underwent normal differentiation in the presence of myrPKB.


Figure 3
View larger version (42K):
[in this window]
[in a new window]
  		FIGURE 3. MyrPKB reverts the effects induced by {Delta}Cam in DN cells. A, Expression of CD2, CD5, HSA, and IL-7R{alpha} is shown for CD25+CD44– DN3 cells of wt, myrPKB tg (PKB), {Delta}Cam tg ({Delta}Cam), and {Delta}Cam/myrPKB double-tg ({Delta}Cam/PKB) mice. Values on top of histogram represent the percentage of cells showing medium and high expression of the indicated surface marker. B, Stronger intracellular Bcl-2 expression in DN thymocytes from {Delta}Cam tg (thin line histogram) compared with {Delta}Cam/myrPKB double-tg (thick line histogram), wt (broken line histogram), and myrPKB tg (dotted line histogram) mice. C, Profiles of annexin V-stained DN3 thymocytes in each group. Values shown in each histogram indicate the percentage of annexin V-positive cells. All data are representative of three experiments with multiple mice analyzed in each group per experiment.

 
To explore whether {Delta}Cam affects the survival of DN3 cells, we examined levels of the antiapoptotic protein Bcl-2 and the degree of apoptosis by annexin V staining. Bcl-2 expression has been described to be high in DN cells and low in most DP cells (49). In DN3 cells of wt and myrPKB tg mice we detected two populations expressing either high or lower levels of Bcl-2 (Fig. 3B). {Delta}Cam DN3 cells instead comprised a homogeneous population expressing very high levels of Bcl-2, which were even above levels detected in control mice. In the presence of myrPKB, Bcl-2 expression was intermediate between {Delta}Cam and wt DN3 cells. In addition, a population with lower Bcl-2 levels was detectable within the DN3 compartment as found in wt cells, presumably representing those cells that have progressed in the differentiation process toward the DN4 stage. Measuring apoptosis by annexin V staining revealed an about 2-fold increase in the apoptosis of DN3 cells in {Delta}Cam tg mice (Fig. 3C). Thus, inhibition of DN3 progression by {Delta}Cam is accompanied by an enhanced induction of Bcl-2 and the absence of overt death of DN3 cells.

MyrPKB rescues Rag and intracellular TCR- beta-chain expression

The block in DN3-DN4 transition of {Delta}Cam cells suggests defects in expression of one or more of the pre-TCR components. CD3{epsilon} expression could be excluded as all CD25+CD44– DN3 cells of {Delta}Cam tg mice expressed levels of CD3{epsilon} comparable to DN3 cells from wt mice (data not shown). However, FACS analysis showed that only 0.1–0.2% of {Delta}Cam DN3 cells contained higher amounts of intracellular TCR-beta protein compared with 13–15% in wt or myrPKB DN3 cells (Fig. 4A). Within the DN4 population, which mainly harbors beta-selected cells, only 14% of cells were found positive for intracellular TCR beta-chain in {Delta}Cam tg mice. Likewise, although all DP cells of wt and myrPKB tg mice expressed intracellular TCR beta-chain, only 43% of the few DP cells arising in {Delta}Cam tg mice had a high level of intracellular TCR-beta protein. Therefore, {Delta}Cam suppresses TCR-beta formation but some {Delta}Cam DN3 cells can aberrantly develop into DP cells in the absence of a functional pre-TCR. Strikingly, simultaneous expression of myrPKB increased the percentage of {Delta}Cam DN3 cells positive for intracellular TCR-beta by 20-fold such that ~45% of DN4 and virtually all DP cells showed normal expression of intracellular TCR-beta protein. Thus, active PKB reverts the defects in intracellular TCR beta-chain formation imposed by hyperactive CN.


Figure 4
View larger version (33K):
[in this window]
[in a new window]
  		FIGURE 4. Expression of myrPKB rescues Rag and intracellular TCR-beta expression (icTCRbeta) in {Delta}Cam DN cells. A, Expression of intracellular TCR-beta protein in DN3, DN4, and DP cells from wt, myrPKB tg (PKB), {Delta}Cam tg ({Delta}Cam), and {Delta}Cam/myrPKB double-tg ({Delta}Cam/PKB) mice is shown. Values with each histogram give the percentage of thymocytes expressing intracellular TCR-beta. B, Reduction of {gamma}{delta} lineage cells in {Delta}Cam mice. DN3 or DN4 cells from wt and {Delta}Cam tg mice were analyzed for cell size (forward light scatter), CD27 (DN3 cells) (top right), or intracellular {gamma}{delta} TCR expression (DN4 cells) (bottom right) by flow cytometry. Values for each histogram are the MFI or the percentage of cells stained positive for intracellular {gamma}{delta} TCR. C and D, MyrPKB rescues the defect in Rag expression imposed by {Delta}Cam. C, Whole cell extracts of unstimulated DN thymocytes from mice as indicated were fractionated by SDS-PAGE and immunoblotted with Rag1 Ab. Protein loading was controlled by beta-actin Ab. D, Total RNA of DN thymocytes from mice as indicated was used for analysis of Rag1 (top) and Rag2 (bottom) mRNA expression by RT-PCR. beta-actin or HPRT PCR was used to control quantity of cDNA used. E, Expression of a tg {alpha}beta TCR partially rescues DN to DP transition in {Delta}Cam tg mice. Thymocytes from newborn OT1-TCR tg (OT1), OT1-TCR/{Delta}Cam double-tg (OT1/{Delta}Cam), and {Delta}Cam tg ({Delta}Cam) mice were analyzed for CD4 and CD8 expression. The percentage of DN and DP cells is indicated (inset) and total thymocyte number (x 106) is given at top of each dot plot. Histograms (bottom) show expression of OT1-TCR-specific V{alpha}2 and Vbeta5 chains on DN3 cells of the indicated mouse lines. The percentage of cells with high expression of the individual TCR chains is shown with each histogram.

 
For further characterization, we analyzed cell size (50) and observed that {Delta}Cam DN3 cells had slightly larger mean fluorescence intensity (MFI 414) than the corresponding wt cells (MFI 387), but within the DN4 population large beta-selected cells were missing (Fig. 4B, left). Likewise, up-regulation of CD27 expression has recently been identified as a marker for beta- or {gamma}{delta}-selected DN3 cells (51), and {Delta}Cam DN3 cells showed significantly higher expression of CD27 (MFI 693) than their wt counterparts (MFI 206) (Fig. 4B, upper right). Furthermore, we could exclude the possibility that {Delta}Cam signaling diverts T cell precursors mainly into the {gamma}{delta} T cell lineage (52, 53, 54) because the percentage of DN4 cells staining positive for intracellular {gamma}{delta} TCR was also greatly reduced (Fig. 4B, lower right). Overall, these analyses show that although {Delta}Cam signaling blocks DN3-DN4 transition, it induces a phenotype in DN3 cells, at least for the analyzed parameters, resembling that of cells that have passed the beta selection checkpoint.

To further dissect the defect in pre-TCR formation, we analyzed the expression of Rag proteins, which are essential for the recombinatorial rearrangements at the TCR beta-chain locus (55). In {Delta}Cam DN cells, Rag1 protein expression was extremely low; however, it was fully restored when myrPKB was coexpressed (Fig. 4C). RT-PCR revealed strongly reduced Rag1 as well as Rag2 mRNA levels in {Delta}Cam DN cells (Fig. 4D), suggesting {Delta}Cam signaling interferes with Rag expression at the transcriptional or posttranscriptional level. Notably, in {Delta}Cam/myrPKB DN cells, Rag1 and Rag2 mRNA expression was rescued. We therefore concluded {Delta}Cam induces a block in early thymocyte development by diminishing Rag1 and Rag2 expression, which would obstruct pre-TCR formation and further differentiation of DN3 cells. Active PKB, acting directly on CN or its targets, overcomes these negative regulatory effects, thereby enabling {Delta}Cam DN3 cells to proceed in differentiation to DP cells.

To analyze whether providing a functional fully rearranged {alpha}beta TCR transgene would overcome the {Delta}Cam-induced differentiation block, we crossed {Delta}Cam tg mice to OT1-TCR tg animals (42). Expression of the OT1-TCR increased the percentage of DP cells in adult {Delta}Cam tg mice to maximally 30% (± 19) vs 5.4% (± 1.5) in {Delta}Cam only and 79.2% (± 0.9) in OT1 tg mice. The total thymocyte number in {Delta}Cam/OT1 double-tg mice was highly variable and increased ~3-fold to 14.0 x 106 (± 20) compared with 3.3 x 106 (± 2.5) in {Delta}Cam and 157.5 x 106 (± 14.6, n = 4) in OT1 tg mice. Similar results were found for newborn mice as shown in Fig. 4E. OT1-TCR expression increased the total thymocyte number and percentage of DP cells by about 3-fold compared with {Delta}Cam tg mice. However, full maturation to CD4highCD8high-expressing DP cells was hampered as the majority of {Delta}Cam/OT1 DP cells had a CD4lowCD8low profile. Analysis of OT1-TCR specific V{alpha}2 and Vbeta5 chains (Fig. 4E, bottom) revealed that the OT1-TCR was properly expressed and that {Delta}Cam actually enhanced the percentage of DN3 cells expressing the tg TCR. These data indicate that expression of a rearranged {alpha}beta TCR promotes transition of {Delta}Cam DN cells to the DP stage but neither full maturation of DP cells nor thymic cellularity is rescued as effectively as was found for myrPKB. MyrPKB therefore evokes regulatory mechanisms in addition to enhancing Rag and intracellular TCR beta-chain expression that are required for an efficient DN3 progression and expansion of {Delta}Cam tg cells.

CsA treatment releases the {Delta}Cam-induced DN3 arrest

Because our previous studies suggested a direct interaction between PKB and NFAT (38), we decided to focus on the regulation of NFAT factors in {Delta}Cam tg mice. First, we investigated whether inhibition of CN, and therefore inhibition of NFAT activity, would restore T cell differentiation in {Delta}Cam tg mice. For this purpose, we cultured newborn thymic lobes from {Delta}Cam tg and wt mice in the presence or absence of CsA, an efficient inhibitor of CN-driven NFAT activation. As shown in Fig. 5A, compared with untreated {Delta}Cam lobes, CsA treatment led within 4 days to a 10-fold increase in thymus cellularity and induced efficient differentiation of {Delta}Cam DN cells to the DP stage (42% vs 0.7% DP cells in untreated lobes). Likewise, CsA treatment restored expression of intracellular TCR-beta protein in {Delta}Cam DN cells to normal level (Fig. 5B). Thus, down-modulation of CN/NFAT activity allows normal expansion and differentiation of otherwise arrested {Delta}Cam DN3 cells.


Figure 5
View larger version (29K):
[in this window]
[in a new window]
  		FIGURE 5. Inhibition of {Delta}Cam activity by CsA rescues thymocyte differentiation. A, Thymic lobes from newborn wt and {Delta}Cam tg ({Delta}Cam) mice were cultured without or with CsA for 4 days. Thymocytes were stained for CD4 and CD8, and thymocyte subsets were determined by FACS analysis. Total thymic cellularity (x 106) is shown at top of plot. Values in each plot represent the percentage of DP thymocytes. B, Thymocytes from lobe cultures described in A were analyzed for intracellular TCR beta-chain expression (icTCRbeta). Histograms are gated on total DN cells and the number with each histogram indicates the percentage of cells positive for intracellular TCR-beta.

 
MyrPKB rescues differentiation by regulating NFAT proteins

In accordance to the role of CN in regulating NFAT proteins and myrPKB’s pivotal effects in {Delta}Cam tg mice, we next asked whether myrPKB counteracts the effects induced by {Delta}Cam by inhibition of NFAT activation. Using confocal microscopy, we studied the nuclear expression of NFATc1 and NFATc3 in DN cells from {Delta}Cam tg and {Delta}Cam/myrPKB double-tg mice. Thymocytes were stained for CD4 and CD8, and NFAT expression was evaluated in CD4–CD8– cells. As evident from Fig. 6, in {Delta}Cam tg mice nuclear NFATc1 expression was very high in the majority (~80%) of DN cells and only ~20% of cells showed lower levels of NFATc1. In high expressing cells, NFATc1 was totally nuclear as judged by staining of nuclei with DAPI (data not shown). Intriguingly, in {Delta}Cam/myrPKB double-tg mice ~70% of DN cells showed lower levels of NFATc1 and only 30% of cells had nuclear NFATc1 levels as high as found in {Delta}Cam DN cells. Importantly, this inverted ratio of NFATc1high vs NFATc1low cells corresponded to the expression level of NFATc1 in DN cells from wt and myrPKB tg mice.


Figure 6
View larger version (51K):
[in this window]
[in a new window]
  		FIGURE 6. MyrPKB down-regulates nuclear NFAT levels in {Delta}Cam DN cells. A, Confocal images of thymocytes surface stained for CD4 (blue) and CD8 (green) and intracellular NFATc1 or NFATc3 (both in red) from {Delta}Cam tg ({Delta}Cam) and {Delta}Cam/myrPKB double-tg ({Delta}Cam/PKB) mice. Arrows indicate representative DN cells in each image showing distribution of NFATc1 or NFATc3. B, Confocal images from thymocytes of wt, PKB, {Delta}Cam tg, and {Delta}Cam/myrPKB double-tg mice stained as described in A were evaluated on the basis of high or low NFATc1 level in CD4–CD8– cells. Data represent the percentage of NFATc1high and NFATc1low cells from 150 to 350 DN cells counted for each group.

 
Similar to NFATc1, the nuclear level of NFATc3 was very high in almost all DN cells of {Delta}Cam tg mice. In contrast, in the presence of myrPKB NFATc3 expression was low in the majority of DN cells of {Delta}Cam tg mice (Fig. 6A, bottom), corresponding to NFAT activity detected in DN cells of wt or myrPKB tg mice (data not shown). From these experiments it is obvious that one pivotal action of myrPKB is the inhibition of NFATc1 and NFATc3 activation in {Delta}Cam DN cells.

NFAT proteins are transcriptional regulators of Rag expression

From many studies it has become evident that hyperactivation of PKB is an essential factor in the induction and progression of tumorigenesis, including T cell lymphoma (56). In conjunction with our finding that myrPKB negatively regulates NFAT activation, we suspected a profound effect on NFAT activation in T cell lymphoma that arises in our myrPKB homozygous (our unpublished data) and other tg mice overexpressing active PKB (57, 58). We therefore analyzed CD4+ T cells from wt mice and myrPKB induced T cell lymphoma for NFAT activation. In wt CD4+ T cells activation of NFATc1 and NFATc2 was clearly detectable 4 h after TCR-CD3 engagement. In contrast, in CD4+ lymphoma cells nuclear levels of NFATc1 and NFATc2 were only marginal (Fig. 7A, top). Intriguingly, in the lymphoma cells we simultaneously detected expression of Rag1 and Rag2 mRNA (Fig. 7A, bottom), supporting the observed link between NFAT activity and Rag transcription in {Delta}Cam tg mice.


Figure 7
View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 7. NFAT factors control Rag expression. A, CD4+ T cells from lymph nodes of wt mice and myrPKB-induced T cell lymphoma (lymph) were stimulated with CD3{epsilon} Abs for 4 h and cytoplasmic (CE) and nuclear protein extracts (NE) were analyzed for NFATc1 and NFATc2 by Western blot (top). CD4+ T cells from wt, myrPKB tg (PKB), and two independent lymphomas as well as total thymocytes from Rag1-deficient (Rag1–/–) mice were analyzed (bottom) for Rag1, Rag2, and beta-actin mRNA expression by RT-PCR. B, NFAT suppresses Rag2 promoter activity. EL4 cells were cotransfected with the Rag2 promoter luciferase reporter construct, {Delta}Cam, and either vector control (vc), NFATc1 (NFc1), or NFATc2 (NFc2) expression vector. After induction of cells with PMA and ionomycin, Rag2 promoter activity was determined. Data are representative of three independent experiments. C, In vivo binding of NFATc1 to the Rag locus. Chromosome and nuclear proteins in wt thymocytes (top) were cross-linked and immunoprecipitated with NFATc1 Ab (NFc1). After release from cross-linking, purified chromosomal DNA was analyzed by PCR for Rag1 and Rag2 promoter and cis-regulatory enhancer elements of the Rag locus (Rag enhancer (4 7 ) and Erag) as described in Materials and Methods. As immunoprecipitation control, isotype-matched control (ic) Ab was used. Input indicates PCR products of chromosomal DNA prior immunoprecipitation. The size of the expected DNA fragments (bp) is indicated. ChIP assays were performed (bottom) using wt and {Delta}Cam tg thymocytes after culture for 4 h in RPMI 1640 medium without or in the presence of CsA (500 ng/ml).

 
Next, we tested the ability of ectopically expressed NFAT to influence Rag promoter activity. EL4 lymphoma cells were transiently transfected with the {Delta}Cam-expressing vector and a luciferase reporter construct harboring nt –251 to nt +147 of the murine Rag2 promoter, which previously was shown to confer lymphocyte-specific promoter activity (44). The Rag2 construct alone produced reproducible and strong luciferase reporter activity, whereas coexpression of NFATc1 or NFATc2 suppressed the Rag2 promoter (Fig. 7B). NFAT factors therefore negatively interfere with Rag2 promoter activity in EL4 cells, results that are in line with the observations in {Delta}Cam tg mice.

Regulation of Rag1 and Rag2 expression is highly complex and depends on the interaction of the promoters with several cis-acting DNA segments (59, 60). To assess the in vivo association of NFAT transcription factors with the Rag locus, we performed ChIP experiments using freshly isolated thymocytes from wt and {Delta}Cam tg mice. As shown in Fig. 7C, NFATc1 binding was detected for the Rag1 and Rag2 promoter but also for selected regions from the described cis-acting element 5' of the Rag2 promoter (45) and the Erag enhancer (46). Binding of NFATc1 to these elements was reduced when {Delta}Cam tg thymocytes were treated with CsA (Fig. 7C, bottom), which inhibits NFAT activation. These results show that NFATc1 binds to the Rag locus, consistent with a regulatory function.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
The targets of pre-TCR-induced calcium flux and NFAT activity (10) are still ill defined. We correlate increased NFAT activity in {Delta}Cam DN cells with defective Rag1, Rag2, and intracellular TCR-beta and {gamma}{delta} TCR expression suggesting that the spatial or temporal and quantitative expression of the individual NFAT members has to be tightly controlled at the DN3-DN4 transition to proceed with normal T cell development. Furthermore, our data highlight PKB as a critical regulator of CN/NFAT-mediated differentiation of T cell precursors as simultaneous expression of myrPKB reverted the profound developmental arrest of {Delta}Cam DN3 cells. Although myrPKB seems to play multiple roles, one essential outcome of myrPKB action is the suppression of NFAT activity in DN3 cells of {Delta}Cam tg mice. Therefore, sustained NFAT activation blocks TCR beta-chain rearrangement and hence pre-TCR formation. In this scenario, suppression of {Delta}Cam-induced NFAT activity to appropriate levels by myrPKB seems to be a prerequisite to proceed with Rag expression and with recombination processes similar to those observed when {Delta}Cam DN cells were treated with the CN inhibitor CsA. Aifantis et al. (10) described a block in maturation of DP cells when day 14.5 fetal lobes were treated with CsA, whereas we found a rescue of DN3 to DP transition in CSA-treated lobes from newborn {Delta}Cam tg mice. These findings reflect that in view of the massive overexpression of NFAT in {Delta}Cam DN3 cells, CsA most likely did not completely block all NFAT activity but rather reduced it to more physiological levels and that NFAT activity could be critical for the differentiation processes before the DN3 stage.

CN/NFAT signaling is known to have positive but also negative effects on gene transcription. For instance, negative regulation is found for the cdk4 gene, which is repressed under basal conditions by NFAT (61). Although {Delta}Cam represses Rag synthesis and intracellular TCR beta-chain synthesis, it simultaneously, at least partially, signals in differentiation. This response is obvious from our observations that despite defective pre-TCR formation, {Delta}Cam DN3 cells showed increased cell size and up-regulated CD2, CD5, and CD27 surface Ags to levels found in cells progressing in differentiation to the DP stage. In contrast, {Delta}Cam DN3 cells failed to decrease Bcl-2 expression. Maintenance of Bcl-2 expression has been described to be a feature of emerging {gamma}{delta} T cells whereas pre-TCR-mediated signaling seems to inhibit Bcl-2 activity (51), but induces the antiapoptotic protein A1, which acts as regulator of pre-T cell survival (62). However, we found no evidence that {Delta}Cam diverts the precursor cells mainly into the {gamma}{delta} lineage because production of intracellular {gamma}{delta} TCR was also reduced. The Bcl-2 promoter contains multiple NFAT consensus sequences, and NFAT involvement in transactivation of the bcl2 gene has been reported for thymocytes (31) and cardiac myocytes (63). Our data therefore strongly suggest that one parameter responsible for heightened Bcl-2 levels in {Delta}Cam DN3 cells is the sustained NFAT activity, which modifies bcl2 transcription.

Besides negatively affecting Rag and intracellular TCR beta-chain expression, sustained CN/NFAT activation seems to evoke inhibitory effects at later stages of DN4 to DP transition because simultaneous expression of the fully rearranged OT1 TCR in {Delta}Cam tg mice only partially restored development of DP cells. MyrPKB, in contrast, rescued differentiation in {Delta}Cam tg mice to almost full extent and one major function of myrPKB in {Delta}Cam DN cells seems to be suppression of NFAT activity. We speculate that besides NFAT, other critical regulators of the DN3-DN4-DP transition such as Notch (64, 65, 66, 67), GATA3 (68), Egr (69), NF-{kappa}B (70), or Wnt signaling (71) among others (9), could be involved. Because Notch signals required for beta selection can be replaced by myrPKB (72) further experimentation concerning this interesting issue is required.

It has become evident that signals from the pre-TCR bifurcate into those that regulate pre-T cell survival and proliferation and those that induce allelic exclusion, a process in which pre-TCR-induced signals terminate further Vbeta-Dbeta-Jbeta rearrangements (50, 73). To date only a few molecules are known that are essential or mimic the ability of the pre-TCR to terminate TCR beta-chain rearrangement. Among these few are the adaptor molecule SLP76 (74), Notch1 (64, 66), and cytosolic protein kinase D (75). Seen from this perspective, sustained levels of active NFAT in {Delta}Cam tg mice could mimic those parts of pre-TCR signaling that initiate allelic exclusion and in {Delta}Cam tg mice, therefore, would lead to premature repression of Rag expression and thus inhibition of pre-TCR formation. MyrPKB instead would down-regulate NFAT activity to levels appropriate for the developmental processes to occur.

Rag expression is regulated at the transcriptional and posttranscriptional level and various cis-regulatory elements controlling Rag transcription have been characterized, including promoter, enhancer, silencer, and anti-silencer elements (59, 60). Known transcription factors involved in T cell-specific Rag expression include c-myb (76), GATA3 (44), and Runx (45), and we have identified NFAT factors as part of the Rag transcriptional machinery. In view of the high number of potential NFAT binding sites within the regulatory elements, which may assist in keeping the Rag locus in an open accessible configuration, it appears that extreme fine tuning in the temporal and spatial activity of the individual NFAT members and their transcriptional partners such as NF-{kappa}B, which is an important regulator of Rag expression in B cells (77), would be necessary to guarantee tissue and developmental stage-specific expression of the Rag proteins.

Although Rag expression in the T cell lineage is thought to be restricted to developing thymocytes, it has also been reported for certain peripheral T cell subsets (78, 79), autoaggressive T cells (80), and lymphoid tumors (81). Furthermore, Rag tg mice show aberrant thymic development and rapidly develop lymphadenopathy and splenomegaly (82). Thus, our finding that transcriptional regulation of the Rag genes involves NFAT factors, which can be controlled by PKB, may also constitute an important pathway in the generation of autoaggressive T cells or malignant transformation in thymus and periphery. In this line, the link between PKB, NFAT, and Rag activity is supported by an almost complete ablation of NFAT activation in myrPKB-induced T cell lymphoma, which intriguingly express Rag1 and Rag2. PKB-mediated down-modulation of NFAT activity may therefore be an essential parameter in the development of T cell malignancies, and targeting NFAT signaling via PKB as such may underscore new therapeutic strategies.


   Acknowledgments
 
We thank S. Roth and T. Rüdiger for valuable help with confocal microscopy, R. Kincaid for the {Delta}Cam construct, A. Rao for NFATc2 Ab, the Serfling laboratory for Abs and discussion, M. Klein for Rag1 knockout mice, and T. Twardzik for collaboration at an early stage of the project. We also thank G. Weitz for technical assistance and H. Wolff for animal maintenance.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a grant to the Forschergruppe 303 from the Deutsche Forschungsgemeinschaft (DFG) and Grant 1054/2-1 from the DFG (to U.H.B.). Back

2 Address correspondence and reprint requests to Dr. Ursula H. Bommhardt at the current address: Institute of Immunology, Otto-von-Guericke University Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, Germany. E-mail address: ursula.bommhardt{at}medizin.uni-magdeburg.de Back

3 Abbreviations used in this paper: DP, double positive; DN, double negative; {Delta}Cam, calcineurin A deletion mutant; PKB, protein kinase B; myrPKB, myristoylated PKB; tg, transgenic; wt, wild type; CN, calcineurin; HPRT, hypoxanthine phosphoribosyltransferase; ChIP, chromatin immunoprecipitation; MFI, mean fluorescence intensity. Back

Received for publication September 30, 2005. Accepted for publication June 22, 2006.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Sebzda, E., S. Mariathasan, T. Ohteki, R. Jones, M. F. Bachmann, P. S. Ohashi. 1999. Selection of the T cell repertoire. Annu. Rev. Immunol. 17: 829-874. [Medline]
  2. Godfrey, D. I., A. Zlotnik. 1993. Control points in early T-cell development. Immunol. Today 14: 547-553. [Medline]
  3. Wilson, A., W. Held, H. R. MacDonald. 1994. Two waves of recombinase gene expression in developing thymocytes. J. Exp. Med. 179: 1355-1360. [Abstract/Free Full Text]
  4. Dudley, E. C., H. T. Petrie, L. M. Shah, M. J. Owen, A. C. Hayday. 1994. T cell receptor beta chain gene rearrangement and selection during thymocyte development in adult mice. Immunity 1: 83-93. [Medline]
  5. Kruisbeek, A. M., M. C. Haks, M. Carleton, A. M. Michie, J. C. Zúñiga-Pflücker, D. L. Wiest. 2000. Branching out to gain control: how the pre-TCR is linked to multiple functions. Immunol. Today 21: 637-644. [Medline]
  6. Khor, B., B. P. Sleckman. 2002. Allelic exclusion at the TCRbeta locus. Curr. Opin. Immunol. 14: 230-234. [Medline]
  7. Michie, A. M., J. C. Zúñiga-Pflücker. 2002. Regulation of thymocyte differentiation: pre-TCR signals and beta-selection. Semin. Immunol. 14: 311-323. [Medline]
  8. Borowski, C., C. Martin, F. Gounari, L. Haughn, I. Aifantis, F. Grassi, H. von Boehmer. 2002. On the brink of becoming a T cell. Curr. Opin. Immunol. 14: 200-206. [Medline]
  9. Rothenberg, E. V., T. Taghon. 2005. Molecular genetics of T cell development. Annu. Rev. Immunol. 23: 601-649. [Medline]
  10. Aifantis, I., F. Gounari, L. Scorrano, C. Borowski, H. von Boehmer. 2001. Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-{kappa}B and NFAT. Nat. Immunol. 2: 403-409. [Medline]
  11. Crabtree, G. R., E. N. Olson. 2002. NFAT signaling: choreographing the social lives of cells. Cell 109: (2 Suppl. 1):S67-S79. [Medline]
  12. Feske, S., H. Okamura, P. G. Hogan, A. Rao. 2003. Ca2+/calcineurin signalling in cells of the immune system. Biochem. Biophys. Res. Commun. 311: 1117-1132. [Medline]
  13. Liu, J., J. D. Farmer, Jr, W. S. Lane, J. Friedman, I. Weissman, S. L. Schreiber. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815. [Medline]
  14. Gao, E. K., D. Lo, R. Cheney, O. Kanagawa, J. Sprent. 1988. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature 336: 176-179. [Medline]
  15. Jenkins, M. K., R. H. Schwartz, D. M. Pardoll. 1988. Effects of cyclosporine A on T cell development and clonal deletion. Science 241: 1655-1658. [Abstract/Free Full Text]
  16. Holländer, G. A., D. A. Fruman, B. E. Bierer, S. J. Burakoff. 1994. Disruption of T cell development and repertoire selection by calcineurin inhibition in vivo. Transplantation 58: 1037-1043. [Medline]
  17. Wang, C. R., K. Hashimoto, S. Kubo, T. Yokochi, M. Kubo, M. Suzuki, K. Suzuki, T. Tada, T. Nakayama. 1995. T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection. J. Exp. Med. 181: 927-941. [Abstract/Free Full Text]
  18. Urdahl, K. B., D. M. Pardoll, M. K. Jenkins. 1994. Cyclosporin A inhibits positive selection and delays negative selection in {alpha}beta TCR transgenic mice. J. Immunol. 152: 2853-2859. [Abstract]
  19. Kane, L. P., S. M. Hedrick. 1996. A role for calcium influx in setting the threshold for CD4+CD8+ thymocyte negative selection. J. Immunol. 156: 4594-4601. [Abstract]
  20. Bueno, O. F., E. B. Brandt, M. E. Rothenberg, J. D. Molkentin. 2002. Defective T cell development and function in calcineurin A beta-deficient mice. Proc. Natl. Acad. Sci. USA 99: 9398-9403. [Abstract/Free Full Text]
  21. Neilson, J. R., M. M. Winslow, E. M. Hur, G. R. Crabtree. 2004. Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity 20: 255-266. [Medline]
  22. Hayden-Martinez, K., L. P. Kane, S. M. Hedrick. 2000. Effects of a constitutively active form of calcineurin on T cell activation and thymic selection. J. Immunol. 165: 3713-3721. [Abstract/Free Full Text]
  23. Serfling, E., F. Berberich-Siebelt, S. Chuvpilo, E. Jankevics, S. Klein-Hessling, T. Twardzik, A. Avots. 2000. The role of NF-AT transcription factors in T cell activation and differentiation. Biochim. Biophys. Acta 1498: 1-18. [Medline]
  24. Hogan, P. G., L. Chen, J. Nardone, A. Rao. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17: 2205-2232. [Free Full Text]
  25. Rengarajan, J., B. Tang, L. H. Glimcher. 2002. NFATc2 and NFATc3 regulate TH2 differentiation and modulate TCR-responsiveness of naive TH cells. Nat. Immunol. 3: 48-54. [Medline]
  26. Chuvpilo, S., E. Jankevics, D. Tyrsin, A. Akimzhanov, D. Moroz, M. K. Jha, J. Schulze-Luehrmann, B. Santner-Nanan, E. Feoktistova, T. König, et al 2002. Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 16: 881-895. [Medline]
  27. Adachi, S., Y. Amasaki, S. Miyatake, N. Arai, M. Iwata. 2000. Successive expression and activation of NFAT family members during thymocyte differentiation. J. Biol. Chem. 275: 14708-14716. [Abstract/Free Full Text]
  28. Amasaki, Y., S. Miyatake, N. Arai, K. Arai. 2000. Regulation of nuclear factor of activated T-cell family transcription factors during T-cell development in the thymus. J. Allergy Clin. Immunol. 106: S1-S9. [Medline]
  29. Yoshida, H., H. Nishina, H. Takimoto, L. E. Marengere, A. C. Wakeham, D. Bouchard, Y. Y. Kong, T. Ohteki, A. Shahinian, M. Bachmann, et al 1998. The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 8: 115-124. [Medline]
  30. Schuh, K., B. Kneitz, J. Heyer, U. Bommhardt, E. Jankevics, F. Berberich-Siebelt, K. Pfeffer, H. K. Müller-Hermelink, A. Schimpl, E. Serfling. 1998. Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur. J. Immunol. 28: 2456-2466. [Medline]
  31. Oukka, M., I.-C. Ho, F. C. de la Brousse, T. Hoey, M. J. Grusby, L. H. Glimcher. 1998. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity 9: 295-304. [Medline]
  32. Scheid, M. P., J. R. Woodgett. 2001. PKB/AKT: functional insights from genetic models. Nat. Rev. Mol. Cell Biol. 2: 760-768. [Medline]
  33. Brazil, D. P., J. Park, B. A. Hemmings. 2002. PKB binding proteins: getting in on the Akt. Cell 111: 293-303. [Medline]
  34. Yang, Z.-Z., O. Tschopp, A. Baudry, B. Dümmler, D. Hynx, B. A. Hemmings. 2004. Physiological functions of protein kinase B/Akt. Biochem. Soc. Trans. 32: (Pt. 2):350-354. [Medline]
  35. Suzuki, A., M. T. Yamaguchi, T. Ohteki, T. Sasaki, T. Kaisho, Y. Kimura, R. Yoshida, A. Wakeham, T. Higuchi, M. Fukumoto, et al 2001. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14: 523-534. [Medline]
  36. Hagenbeek, T. J., M. Naspetti, F. Malergue, F. Garçon, J. A. Nunès, K. B. Cleutjens, J. Trapman, P. Krimpenfort, H. Spits. 2004. The loss of PTEN allows TCR {alpha}beta lineage thymocytes to bypass IL-7 and pre-TCR-mediated signaling. J. Exp. Med. 200: 883-894. [Abstract/Free Full Text]
  37. Hinton, H. J., D. R. Alessi, D. A. Cantrell. 2004. The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development. Nat. Immunol. 5: 539-545. [Medline]
  38. Patra, A. K., S. Y. Na, U. Bommhardt. 2004. Active protein kinase B regulates TCR responsiveness by modulating cytoplasmic-nuclear localization of NFAT and NF-{kappa}B proteins. J. Immunol. 172: 4812-4820. [Abstract/Free Full Text]
  39. Parsons, J. N., G. J. Wiederrecht, S. Salowe, J. J. Burbaum, L. L. Rokosz, R. L. Kincaid, S. J. O’Keefe. 1994. Regulation of calcineurin phosphatase activity and interaction with the FK-506.FK-506 binding protein complex. J. Biol. Chem. 269: 19610-19616. [Abstract/Free Full Text]
  40. Weih, F., S. A. Lira, R. Bravo. 1996. Overexpression of RelB in transgenic mice does not affect I{kappa}B{alpha} levels: differential regulation of RelA and RelB by the inhibitor protein. Oncogene 12: 445-449. [Medline]
  41. Na, S. Y., A. Patra, Y. Scheuring, A. Marx, M. Tolaini, D. Kioussis, B. Hemmings, T. Hünig, U. Bommhardt. 2003. Constitutively active protein kinase B enhances Lck and Erk activities and influences thymocyte selection and activation. J. Immunol. 171: 1285-1296. [Abstract/Free Full Text]
  42. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27. [Medline]
  43. Wilson, A., H. R. MacDonald. 1995. Expression of genes encoding the pre-TCR and CD3 complex during thymus development. Int. Immunol. 7: 1659-1664. [Abstract/Free Full Text]
  44. Kishi, H., X. C. Wei, Z. X. Jin, Y. Fujishiro, T. Nagata, T. Matsuda, A. Muraguchi. 2000. Lineage-specific regulation of the murine RAG-2 promoter: GATA-3 in T cells and Pax-5 in B cells. Blood 95: 3845-3852. [Abstract/Free Full Text]
  45. Yannoutsos, N., V. Barreto, Z. Misulovin, A. Gazumyan, W. Yu, N. Rajewsky, B. R. Peixoto, T. Eisenreich, M. C. Nussenzweig. 2004. A cis element in the recombination activating gene locus regulates gene expression by counteracting a distant silencer. Nat. Immunol. 5: 443-450. [Medline]
  46. Hsu, L. Y., J. Lauring, H. E. Liang, S. Greenbaum, D. Cado, Y. Zhuang, M. S. Schlissel. 2003. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19: 105-117. [Medline]
  47. Rodewald, H. R., K. Awad, P. Moingeon, L. D’Adamio, D. Rabinowitz, Y. Shinkai, F. W. Alt, E. L. Reinherz. 1993. Fc{gamma}RII/III and CD2 expression mark distinct subpopulations of immature CD4–CD8– murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status. J. Exp. Med. 177: 1079-1092. [Abstract/Free Full Text]
  48. Azzam, H. S., A. Grinberg, K. Lui, H. Shen, E. W. Shores, P. E. Love. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188: 2301-2311. [Abstract/Free Full Text]
  49. Gratiot-Deans, J., L. Ding, L. A. Turka, G. Nunez. 1993. bcl-2 proto-oncogene expression during human T cell development: evidence for biphasic regulation. J. Immunol. 151: 83-91. [Abstract]
  50. Hoffman, E. S., L. Passoni, T. Crompton, T. M. Leu, D. G. Schatz, A. Koff, M. J. Owen, A. C. Hayday. 1996. Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev. 10: 948-962. [Abstract/Free Full Text]
  51. Taghon, T., M. A. Yui, R. Pant, R. A. Diamond, E. V. Rothenberg. 2006. Developmental and molecular characterization of emerging beta- and {gamma}{delta}-selected pre-T cells in the adult mouse thymus. Immunity 24: 53-64. [Medline]
  52. Hayday, A. C., D. F. Barber, N. Douglas, E. S. Hoffman. 1999. Signals involved in {gamma}/{delta} T cell versus {alpha}/beta T cell lineage commitment. Semin. Immunol. 11: 239-249. [Medline]
  53. Haks, M. C., J. M. Lefebvre, J. P. Lauritsen, M. Carleton, M. Rhodes, T. Miyazaki, D. J. Kappes, D. L. Wiest. 2005. Attenuation of {gamma}{delta}TCR signaling efficiently diverts thymocytes to the {alpha}beta lineage. Immunity 22: 595-606. [Medline]
  54. Hayes, S. M., L. Li, P. E. Love. 2005. TCR signal strength influences {alpha}beta/{gamma}{delta} lineage fate. Immunity 22: 583-593. [Medline]
  55. Oettinger, M. A., D. G. Schatz, C. Gorka, D. Baltimore. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248: 1517-1523. [Abstract/Free Full Text]
  56. Nicholson, K. M., N. G. Anderson. 2002. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381-395. [Medline]
  57. Malstrom, S., E. Tili, D. Kappes, J. D. Ceci, P. N. Tsichlis. 2001. Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. Proc. Natl. Acad. Sci. USA 98: 14967-14972. [Abstract/Free Full Text]
  58. Rathmell, J. C., R. L. Elstrom, R. M. Cinalli, C. B. Thompson. 2003. Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur. J. Immunol. 33: 2223-2232. [Medline]
  59. Schlissel, M. S.. 2003. Regulating antigen-receptor gene assembly. Nat. Rev. Immunol. 3: 890-899. [Medline]
  60. Jung, D., F. W. Alt. 2004. Unraveling V(D)J recombination: insights into gene regulation. Cell 116: 299-311. [Medline]
  61. Baksh, S., H. R. Widlund, A. A. Frazer-Abel, J. Du, S. Fosmire, D. E. Fisher, J. A. DeCaprio, J. F. Modiano, S. J. Burakoff. 2002. NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol. Cell 10: 1071-1081. [Medline]
  62. Mandal, M., C. Borowski, T. Palomero, A. A. Ferrando, P. Oberdoerffer, F. Meng, A. Ruiz-Vela, M. Ciofani, J. C. Zúñiga-Pflücker, I. Screpanti, et al 2005. The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J. Exp. Med. 201: 603-614. [Abstract/Free Full Text]
  63. Kawamura, T., K. Ono, T. Morimoto, M. Akao, E. Iwai-Kanai, H. Wada, N. Sowa, T. Kita, K. Hasegawa. 2004. Endothelin-1-dependent nuclear factor of activated T lymphocyte signaling associates with transcriptional coactivator p300 in the activation of the B cell leukemia-2 promoter in cardiac myocytes. Circ. Res. 94: 1492-1499. [Abstract/Free Full Text]
  64. Wolfer, A., A. Wilson, M. Nemir, H. R. MacDonald, F. Radtke. 2002. Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early {alpha}beta lineage thymocytes. Immunity 16: 869-879. [Medline]
  65. Huang, E. Y., A. M. Gallegos, S. M. Richards, S. M. Lehar, M. J. Bevan. 2003. Surface expression of Notch1 on thymocytes: correlation with the double-negative to double-positive transition. J. Immunol. 171: 2296-2304. [Abstract/Free Full Text]
  66. Ciofani, M., T. M. Schmitt, A. Ciofani, A. M. Michie, N. Cuburu, A. Aublin, J. L. Maryanski, J. C. Zúñiga-Pflücker. 2004. Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. J. Immunol. 172: 5230-5239. [Abstract/Free Full Text]
  67. Visan, I., J. S. Yuan, J. B. Tan, K. Cretegny, C. J. Guidos. 2006. Regulation of intrathymic T-cell development by Lunatic Fringe- Notch1 interactions. Immunol. Rev. 209: 76-94. [Medline]
  68. Pai, S.-Y., M. L. Truitt, C.-N. Ting, J. M. Leiden, L. H. Glimcher, I.-C. Ho. 2003. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19: 863-875. [Medline]
  69. Carleton, M., M. C. Haks, S. A. Smeele, A. Jones, S. M. Belkowski, M. A. Berger, P. Linsley, A. M. Kruisbeek, D. L. Wiest. 2002. Early growth response transcription factors are required for development of CD4–CD8– thymocytes to the CD4+CD8+ stage. J. Immunol. 168: 1649-1658. [Abstract/Free Full Text]
  70. Voll, R. E., E. Jimi, R. J. Phillips, D. F. Barber, M. Rincon, A. C. Hayday, R. A. Flavell, S. Ghosh. 2000. NF-{kappa}B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity 13: 677-689. [Medline]
  71. Staal, F. J., F. Weerkamp, A. W. Langerak, R. W. Hendriks, H. C. Clevers. 2001. Transcriptional control of T lymphocyte differentiation. Stem Cells 19: 165-179. [Medline]
  72. Ciofani, M., J. C. Zúñiga-Pflücker. 2005. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat. Immunol. 6: 881-888. [Medline]
  73. Aifantis, I., J. Buer, H. von Boehmer, O. Azogui. 1997. Essential role of the pre-T cell receptor in allelic exclusion of the T cell receptor beta locus [Published erratum appears in 1997 Immunity 7: 895.]. Immunity 7: 601-607. [Medline]
  74. Aifantis, I., V. I. Pivniouk, F. Gartner, J. Feinberg, W. Swat, F. W. Alt, H. von Boehmer, R. S. Geha. 1999. Allelic exclusion of the T cell receptor beta locus requires the SH2 domain-containing leukocyte protein (SLP)-76 adaptor protein. J. Exp. Med. 190: 1093-1102. [Abstract/Free Full Text]
  75. Marklund, U., K. Lightfoot, D. Cantrell. 2003. Intracellular location and cell context-dependent function of protein kinase D. Immunity 19: 491-501. [Medline]
  76. Wang, Q. F., J. Lauring, M. S. Schlissel. 2000. c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells. Mol. Cell Biol. 20: 9203-9211. [Abstract/Free Full Text]
  77. Verkoczy, L., D. Ait-Azzouzene, P. Skog, A. Martensson, J. Lang, B. Duong, D. Nemazee. 2005. A role for nuclear factor {kappa}B/rel transcription factors in the regulation of the recombinase activator genes. Immunity 22: 519-531. [Medline]
  78. McMahan, C. J., P. J. Fink. 1998. RAG reexpression and DNA recombination at T cell receptor loci in peripheral CD4+ T cells. Immunity 9: 637-647. [Medline]
  79. Serra, P., A. Amrani, B. Han, J. Yamanouchi, S. J. Thiessen, P. Santamaria. 2002. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes. Proc. Natl. Acad. Sci. USA 99: 15566-15571. [Abstract/Free Full Text]
  80. Vaitaitis, G. M., M. Poulin, R. J. Sanderson, K. Haskins, D. H. Wagner, Jr. 2003. Cutting edge: CD40-induced expression of recombination activating gene (RAG)1 and RAG2: a mechanism for the generation of autoaggressive T cells in the periphery. J. Immunol. 170: 3455-3459. [Abstract/Free Full Text]
  81. Oettinger, M. A.. 2004. How to keep V(D)J recombination under control. Immunol. Rev. 200: 165-181. [Medline]
  82. Wayne, J., H. Suh, Z. Misulovin, K. A. Sokol, K. Inaba, M. C. Nussenzweig. 1994. A regulatory role for recombinase activating genes, RAG-1 and RAG-2, in T cell development. Immunity 1: 95-107. [Medline]



This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
A. Akimzhanov, L. Krenacs, T. Schlegel, S. Klein-Hessling, E. Bagdi, E. Stelkovics, E. Kondo, S. Chuvpilo, P. Wilke, A. Avots, et al.
Epigenetic Changes and Suppression of the Nuclear Factor of Activated T Cell 1 (NFATC1) Promoter in Human Lymphomas with Defects in Immunoreceptor Signaling
Am. J. Pathol., January 1, 2008; 172(1): 215 - 224.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patra, A. K.
Right arrow Articles by Bommhardt, U. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patra, A. K.
Right arrow Articles by Bommhardt, U. H.
Right arrowPubmed/NCBI databases
*Substance via MeSH

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS